CS386891A3 - Cephalosporin derivative, process of its preparation and a pharmaceuticalcomprising thereof - Google Patents
Cephalosporin derivative, process of its preparation and a pharmaceuticalcomprising thereof Download PDFInfo
- Publication number
- CS386891A3 CS386891A3 CS913868A CS386891A CS386891A3 CS 386891 A3 CS386891 A3 CS 386891A3 CS 913868 A CS913868 A CS 913868A CS 386891 A CS386891 A CS 386891A CS 386891 A3 CS386891 A3 CS 386891A3
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- oxo
- formula
- amino
- carboxy
- piperazinyl
- Prior art date
Links
- 0 *=C(C(NC([C@@]1SCC(CN(CC2)CCN2c(cc(c2c3)N(C4CC4)C=C(C(O)=O)C2=O)c3F)=C(C(O)=O)N11)*1=O)=O)c1c[s]c(N)n1 Chemical compound *=C(C(NC([C@@]1SCC(CN(CC2)CCN2c(cc(c2c3)N(C4CC4)C=C(C(O)=O)C2=O)c3F)=C(C(O)=O)N11)*1=O)=O)c1c[s]c(N)n1 0.000 description 4
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
- C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63071590A | 1990-12-20 | 1990-12-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS386891A3 true CS386891A3 (en) | 1992-07-15 |
Family
ID=24528317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS913868A CS386891A3 (en) | 1990-12-20 | 1991-12-18 | Cephalosporin derivative, process of its preparation and a pharmaceuticalcomprising thereof |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0492277A3 (is) |
| JP (1) | JPH04334387A (is) |
| KR (1) | KR920012094A (is) |
| AU (1) | AU8994791A (is) |
| BR (1) | BR9105405A (is) |
| CA (1) | CA2057777A1 (is) |
| CS (1) | CS386891A3 (is) |
| FI (1) | FI916011A7 (is) |
| HU (1) | HU914006D0 (is) |
| IE (1) | IE914451A1 (is) |
| IL (1) | IL100407A0 (is) |
| IS (1) | IS3795A7 (is) |
| MX (1) | MX9102683A (is) |
| YU (1) | YU195591A (is) |
| ZA (1) | ZA919905B (is) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0550775A1 (en) * | 1992-01-07 | 1993-07-14 | F. Hoffmann-La Roche Ag | Cephalosporin derivatives |
| DE4234078A1 (de) * | 1992-10-09 | 1994-04-14 | Bayer Ag | Chinoloncarbonsäuren |
| MX9505113A (es) * | 1995-12-07 | 1997-06-28 | Aranda Lab Sa De Cv | Derivados de cephalosporin fluoroquinolonatos y composiciones farmaceuticas que los contengan. |
| US7847093B2 (en) | 2003-04-16 | 2010-12-07 | Sandoz Ag | Processes for the preparations of cefepime |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1277977C (en) * | 1985-01-21 | 1990-12-18 | Shigeo Shimizu | Beta-lactam antibiotics |
| YU63689A (en) * | 1988-03-31 | 1991-06-30 | Hoffmann La Roche | Acyl derivatives |
| US5143910A (en) * | 1989-09-07 | 1992-09-01 | Shionogi & Co., Ltd. | Piperaziniocephalosporins |
| DK0525057T3 (da) * | 1990-04-18 | 2000-07-31 | Procter & Gamble Pharma | Antimikrobielle quinolonyllactamer |
-
1991
- 1991-12-11 EP EP19910121222 patent/EP0492277A3/en not_active Withdrawn
- 1991-12-13 BR BR919105405A patent/BR9105405A/pt unknown
- 1991-12-17 CA CA002057777A patent/CA2057777A1/en not_active Abandoned
- 1991-12-17 ZA ZA919905A patent/ZA919905B/xx unknown
- 1991-12-18 CS CS913868A patent/CS386891A3/cs unknown
- 1991-12-18 JP JP3353054A patent/JPH04334387A/ja active Pending
- 1991-12-18 HU HU914006A patent/HU914006D0/hu unknown
- 1991-12-18 IL IL100407A patent/IL100407A0/xx unknown
- 1991-12-19 MX MX9102683A patent/MX9102683A/es unknown
- 1991-12-19 YU YU195591A patent/YU195591A/sh unknown
- 1991-12-19 FI FI916011A patent/FI916011A7/fi not_active Application Discontinuation
- 1991-12-19 IS IS3795A patent/IS3795A7/is unknown
- 1991-12-19 AU AU89947/91A patent/AU8994791A/en not_active Abandoned
- 1991-12-19 KR KR1019910023421A patent/KR920012094A/ko not_active Withdrawn
- 1991-12-19 IE IE445191A patent/IE914451A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| FI916011A7 (fi) | 1992-06-21 |
| EP0492277A3 (en) | 1992-10-14 |
| IS3795A7 (is) | 1992-06-21 |
| YU195591A (sh) | 1994-01-20 |
| BR9105405A (pt) | 1992-08-25 |
| IL100407A0 (en) | 1992-09-06 |
| CA2057777A1 (en) | 1992-06-21 |
| IE914451A1 (en) | 1992-07-01 |
| ZA919905B (en) | 1992-08-26 |
| FI916011A0 (fi) | 1991-12-19 |
| MX9102683A (es) | 1992-06-01 |
| HU914006D0 (en) | 1992-03-30 |
| KR920012094A (ko) | 1992-07-25 |
| JPH04334387A (ja) | 1992-11-20 |
| EP0492277A2 (en) | 1992-07-01 |
| AU8994791A (en) | 1992-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR0133560B1 (ko) | 세펨 화합물, 이의 제조방법 및 이를 포함하는 약제학적 조성물 | |
| FI87925C (fi) | Foerfarande foer framstaellning av farmakologiskt vaerdefull kefemfoerening | |
| EP0286145A2 (en) | 3-Heterocyclylthiomethyl cephalosporins | |
| JPS6145995B2 (is) | ||
| IE48942B1 (en) | 3-unsubstituted-3-cephem compounds | |
| JPS63132893A (ja) | 新規セフアロスポリン誘導体、その製法およびそれらを有効成分とする抗菌剤 | |
| HU211940A9 (en) | Water-soluble antibiotic composition and water-soluble salts of cephem compounds | |
| CS386891A3 (en) | Cephalosporin derivative, process of its preparation and a pharmaceuticalcomprising thereof | |
| JPH01261392A (ja) | アシル誘導体及びその製造方法 | |
| EP0266060A2 (en) | Cephalosporins, process for their preparation and pharmaceutical compositions containing them | |
| JPS62158291A (ja) | セフアロスポリン誘導体 | |
| EP0186463A2 (en) | Beta-lactam antibiotics | |
| EP0193858B1 (en) | New 1-oxa-1-dethia-cephalosporin compounds and antibacterial agent comprising the same | |
| JPH08319291A (ja) | 新規セフェム誘導体 | |
| FI73442B (fi) | Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara (6r,7r)-7-/2-(2-amino-4-tiazolyl)-2- hydroxiimino)acetamido/-3-//(substituerad-as-triazin-3-yl)tio/metyl/ -8-oxo-5-tia-1-azabicyklo/4.2.0/okt-2-en-2-karboxylsyror. | |
| JPS62167784A (ja) | 新規セフアロスポリン誘導体、その製法およびそれらを有効成分とする抗菌剤 | |
| JPS6236387A (ja) | ３，７−ジ置換−３−セフエム化合物およびその製法 | |
| EP0550775A1 (en) | Cephalosporin derivatives | |
| JPH093074A (ja) | セファロスポリン化合物、その用途および中間体化合物 | |
| EP0212923A2 (en) | Cephalosporin derivatives | |
| FI67084B (fi) | Vid framstaellning av terapeutiskt vaerdefulla cefalosporiner anvaendbara 7-(2-(2-(skyddad-amino)-4-tiazolyl)-2-metoxiiminoacetamido)cefalosporinderivat | |
| EP0178527A2 (en) | Cephalosporin compounds and process for their preparation | |
| US4554350A (en) | 3-(1-Halo-2-oxoethyl)cephalosporin intermediates | |
| JPH0687865A (ja) | 新規な１−オキサ−１−デチアセフエム化合物 | |
| GB2197649A (en) | 7-( alpha -(2-amino-4-thiazolyl)- alpha -oximino-acclamido)-cephem antibiotics |